These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31592444)

  • 21. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical utility curve: a proposal to improve the translation of information provided by prediction models to clinicians.
    Campbell DJ
    BMC Res Notes; 2016 Apr; 9():219. PubMed ID: 27080381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical inference for decision curve analysis, with applications to cataract diagnosis.
    Sande SZ; Li J; D'Agostino R; Yin Wong T; Cheng CY
    Stat Med; 2020 Sep; 39(22):2980-3002. PubMed ID: 32667093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical significance testing and p-values: Defending the indefensible? A discussion paper and position statement.
    Griffiths P; Needleman J
    Int J Nurs Stud; 2019 Nov; 99():103384. PubMed ID: 31442781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expected clinical utility of automatable prediction models for improving palliative and end-of-life care outcomes: Toward routine decision analysis before implementation.
    Taseen R; Ethier JF
    J Am Med Inform Assoc; 2021 Oct; 28(11):2366-2378. PubMed ID: 34472611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency department triage prediction of clinical outcomes using machine learning models.
    Raita Y; Goto T; Faridi MK; Brown DFM; Camargo CA; Hasegawa K
    Crit Care; 2019 Feb; 23(1):64. PubMed ID: 30795786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies.
    Russo S; Monzani D; Pinto CA; Vergani L; Marton G; Falahee M; Simons G; Whichello C; Kihlbom U; Pravettoni G
    Patient Prefer Adherence; 2021; 15():1331-1345. PubMed ID: 34177261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
    Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
    J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of likelihood ratios for comparisons of binary diagnostic tests: underlying ROC curves.
    Bandos AI; Rockette HE; Gur D
    Med Phys; 2010 Nov; 37(11):5821-30. PubMed ID: 21158294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Net benefit of routine urine parameters for urinary tract infection screening: a decision curve analysis.
    Han YQ; Zhang L; Wang JR; Xu SC; Hu ZD
    Ann Transl Med; 2020 May; 8(9):601. PubMed ID: 32566627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves.
    Carter JV; Pan J; Rai SN; Galandiuk S
    Surgery; 2016 Jun; 159(6):1638-1645. PubMed ID: 26962006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a Nomogram for the Prediction of Unfavorable Treatment Outcome Among Multi-Drug Resistant Tuberculosis Patients in North West Ethiopia: An Application of Prediction Modelling.
    Anley DT; Akalu TY; Merid MW; Tsegaye T
    Infect Drug Resist; 2022; 15():3887-3904. PubMed ID: 35903578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient preferences for the treatment of type 2 diabetes: a scoping review.
    Joy SM; Little E; Maruthur NM; Purnell TS; Bridges JF
    Pharmacoeconomics; 2013 Oct; 31(10):877-92. PubMed ID: 24081453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective thoracic fusion in AIS curves: the definition of target outcomes improves the prediction of spontaneous lumbar curve correction (SLCC).
    Koller H; Meier O; Albrecht H; Schmidt R; Zenner J; Hitzl W
    Eur Spine J; 2014 Jun; 23(6):1263-81. PubMed ID: 24682377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.